Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
Androgenetic Alopecia
About this trial
This is an interventional treatment trial for Androgenetic Alopecia
Eligibility Criteria
Inclusion Criteria:
- Men between the ages 18-65.
- Disease Stage: Norwood Hamilton IIIa-IV.
- Length of time with disease < 10 years.
Exclusion Criteria:
- Must not have other concurrent hair disease.
- Have not used any oral anti androgen (Finasteride or Dutasteride) in the past six months. If so, a washout period is needed. One month for Finasteride and three months for Dutasteride.
- Patients under the age of 18.
- Patients who are unable to offer consent.
Sites / Locations
- The Skin Care CentreRecruiting
Arms of the Study
Arm 1
Experimental
Microneedling
By randomization, the side for treatment will be determined. Topical anaesthetic will be then placed onto the treatment area under occlusion for thirty minutes to one hour. This will then be removed with 70% alcohol. The area will be rolled with microneedles in two planes: coronally and sagitally. In each plane, five passes will be made. Patients will restart application of Minoxidil the following day to both sides of the lesion. The same half of the scalp will be treated for the rest of the sessions, with topical anaesthetic applied by patient 30 minutes to an hour prior to start of treatment session. Patients will undergo microneedling on alternate weeks for a total of six treatments in 12 weeks. If there is >30% growth seen after six weeks, then the entire area will be treated.